Clinical Trial Update: Trazodone for Sleep Disorders in Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating trazodone for sleep disorders in Alzheimer's disease has completed. The document does not report the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Insomnia

Drugs mentioned

• Trazodone (trazodone)

Snippet

Sponsor: Brasilia University Hospital | Conditions: Sleep, Sleep Disorders | Phase 3 | Status: COMPLETED